Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 17.
doi: 10.1007/s11030-023-10805-5. Online ahead of print.

Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor

Affiliations

Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor

Komal Zia et al. Mol Divers. .

Abstract

Given the increasing effectiveness of immune-based therapies, management of their associated toxicities is of utmost importance. Cytokine release syndrome (CRS), characterized by elevated levels of cytokine, poses a significant challenge following the administration of antibodies and CAR-T cell therapies. CRS also contributes to multiple organ dysfunction in severe viral infections, notably in COVID-19. Given the pivotal role of IL-6 cytokine in initiating CRS, it has been considered a most potential therapeutic target to mitigate hyperactivated immune responses. While monoclonal antibodies of IL-6 show promise in mitigating cytokine storm, concerns about immunotoxicity persist, and small molecule IL-6 antagonists remain unavailable. The present study employed sophisticated computational techniques to identify potential hit compounds as IL-6 inhibitors, with the aim of inhibiting IL-6/IL-6R protein-protein interactions. Through ligand-based pharmacophore mapping and shape similarity in combination with docking-based screening, we identified nine hit compounds with diverse chemical scaffolds as potential binders of IL-6. Further, the MD simulation of 300 ns of five virtual hits in a complex with IL-6 was employed to study the dynamic behavior. To provide a more precise prediction, binding free energy was also estimated. The identified compounds persistently interacted with the residues lining the binding site of the IL-6 protein. These compounds displayed low binding energy during MMPBSA calculations, substantiating their strong association with IL-6. This study suggests promising scaffolds as potential inhibitors of IL-6/IL-6R protein-protein interactions and provides direction for lead optimization.

Keywords: COVID-19; Cytokine release syndrome; Interleukin 6; MD simulation; Protein–protein interactions.

PubMed Disclaimer

Similar articles

References

    1. Fajgenbaum DC, June CH (2020) Cytokine storm. N Engl J Med 383:2255–2273. https://doi.org/10.1056/NEJMra2026131 - DOI - PubMed - PMC
    1. Shimabukuro-Vornhagen A, Gödel P, Subklewe M et al (2018) Cytokine release syndrome. J Immunother Cancer 6:56. https://doi.org/10.1186/s40425-018-0343-9 - DOI - PubMed - PMC
    1. Fagan N, Meah N, York K et al (2021) Shedding light on therapeutics in alopecia and their relevance to COVID-19. Clin Dermatol 39:76–83. https://doi.org/10.1016/j.clindermatol.2020.12.015 - DOI - PubMed
    1. Hojyo S, Uchida M, Tanaka K et al (2020) How COVID-19 induces cytokine storm with high mortality. Inflamm Regener 40:37. https://doi.org/10.1186/s41232-020-00146-3 - DOI
    1. Wang C, Xie J, Zhao L et al (2020) Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. eBioMedicine 57:e102833. https://doi.org/10.1016/j.ebiom.2020.102833 - DOI

LinkOut - more resources